BITI-OLD
BIOTIE THERAPIES OYJ-ADR
BIOTIE THERAPIES OYJ-ADR historical holders
total: 1
Baupost Group BIOTIE THERAPIES OYJ-ADR transactions over time
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Held since:
- 2015 Q2
- Held for:
- 4 quarters
- Latest activity:
- 2016 Q2
Seth Klarman has been an institutional investor in BIOTIE THERAPIES OYJ-ADR (BITI-OLD) since 2015 Q2. According to 2026 Q1 report, Seth Klarman doesn't hold any shares. The fund/company first acquired BITI-OLD in 2015 Q2, initially purchasing 869,643 shares. Since the initial investment, Baupost Group has made 3 more transactions in this position.
When did Seth Klarman exit their BITI-OLD position?
Seth Klarman no longer holds BIOTIE THERAPIES OYJ-ADR (BITI-OLD). They sold off their entire position in 2016 Q2, closing out an investment that began in 2015 Q2.
When did Seth Klarman first invest in BITI-OLD?
Seth Klarman first invested in BIOTIE THERAPIES OYJ-ADR (BITI-OLD) in 2015 Q2 at the reported quarter-end price of $19.97 per share, acquiring 869,643 shares in their initial purchase.
What is Seth Klarman's average cost basis for BITI-OLD?
Based on historical transaction data, Seth Klarman's estimated cost basis for BIOTIE THERAPIES OYJ-ADR (BITI-OLD) is approximately $17.51 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $17.50
- Weighted AVG sell price:
- $26.39
BITI-OLD transactions history by Baupost Group
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q2
|
0.00%
|
$26.39
|
-100% (-1,395,000)
|
|||
|
2015 Q4
|
0.36%
|
$14.35
|
+11.07% (+138,994)
|
|||
|
2015 Q3
|
0.27%
|
$13.09
|
+44.43% (+386,363)
|
|||
|
2015 Q2
|
0.29%
|
$19.97
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.